CARGO Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
I'm PortAI, I can summarize articles.
CARGO Therapeutics Inc reported a quarterly adjusted loss of $1.04 per share for the quarter ended June 30, missing analyst expectations of a loss of 62 cents. The company had a total loss of $49.94 million, with reported revenue at zero. Despite an 8.7% rise in shares this quarter, they have lost 68.9% year-to-date. Analysts maintain a "hold" rating on the stock, with no revisions in earnings estimates over the past month. The average consensus for the biotechnology sector remains a "buy."
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments